
BioXcel Therapeutics Inc (BTAI) poses a Brand-New Opportunity for Investors with beta value of -0.06
BioXcel Therapeutics Inc (NASDAQ: BTAI) established initial surge of 11.78% at $3.32, as the Stock market unbolted on Wednesday, before settling in for the price